12 Dec

HoLISTIC Consortium utilised LaRDR data for model validation

News, Newsletter

LaRDR contributed Hodgkin lymphoma data to the international consortium Hodgkin Lymphoma International Study for Individual Care (HoLISTIC). The registry data were used in the external validation of a clinical prediction model in patients with advanced-stage classical Hodgkin lymphoma. Read more in the publication in the Journal of Clinical Oncology.

Navigate to Research for more publications and presentations of LaRDR.

December 2022 newslet… November 30, 2022 Ibrutinib MCL manuscr… December 21, 2022